SSKN - STRATA Skin Sciences, Inc.
| Previous Close | 3.27 |
| Open | 3.27 |
| Bid | 3.18 x 800 |
| Ask | 3.50 x 800 |
| Day's Range | 3.20 - 3.32 |
| 52 Week Range | 1.06 - 3.88 |
| Volume | 42,997 |
| Avg. Volume | 295,990 |
| Market Cap | 107.859M |
| Beta (3Y Monthly) | 0.89 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -3.08 |
| Earnings Date | May 9, 2018 - May 14, 2018 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 5.00 |
- GlobeNewswire•12 hours ago
STRATA Skin Sciences to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Dr. Dolev Rafaeli, STRATA’s Chief Executive Officer, will present a corporate overview at the Dawson James Securities 4th Annual Small Cap Growth Conference at the Wyndham Grand Hotel in Jupiter, Florida on Tuesday, October 30th at 11:30 am Eastern Time.
- GlobeNewswire•7 days ago
STRATA Skin Sciences Announces Launch of the XTRAC® S3™
STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the launch of the new XTRAC S3 308nm Laser at the American Society for Dermatologic Surgery meeting on October 11, 2018 at the JW Marriott in Phoenix Arizona. The next generation XTRAC, the S3, is smaller, faster and smarter.
- GlobeNewswire•16 days ago
STRATA Skin Sciences Announces Completion of a Clinical Study and the First Commercial Account for its Multi Micro Dose™ Diagnostic Tip Accessory for the XTRAC® 308nm Excimer Laser
STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced the completion of a multi-center clinical study investigating the efficiency and efficacy of its FDA cleared Multi-Micro Dose™ (“MMD”) diagnostic tip accessory for the proprietary XTRAC® 308nm excimer laser. Three separate clinics utilized the patent-pending MMD tip, in conjunction with the XTRAC laser, to filter the narrow band UVB light at delivery in order to calculate and customize the maximum non-blistering dose for each of the participating patients in the study.
- Simply Wall St.•20 days ago
Who Really Owns STRATA Skin Sciences Inc (NASDAQ:SSKN)?
The big shareholder groups in STRATA Skin Sciences Inc (NASDAQ:SSKN) have power over the company. Institutions often own shares in more established companies, while it’s not unusual to see insiders Read More...
- GlobeNewswire•23 days ago
STRATA Skin Sciences to Participate in Ladenburg Thalmann 2018 Healthcare Conference
STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Dr. Dolev Rafaeli, STRATA’s Chief Executive Officer, will present a corporate overview at the Ladenburg Thalmann 2018 Healthcare Conference at the Sofitel New York Hotel at 45 West 44th Street, New York on Tuesday, October 2nd at 8:30 am Eastern Time. STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions.
- GlobeNewswire•last month
STRATA Skin Sciences to Participate in Panel Discussion at The MedTech Conference
STRATA Skin Sciences is a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions.
- GlobeNewswire•2 months ago
STRATA Skin Sciences to Participate in H.C. Wainwright’s 20th Annual Global Investment Conference
STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that Dr. Dolev Rafaeli, STRATA’s Chief Executive Officer, will present a corporate overview at the H. C. Wainwright 20th Annual Global Investment Conference at the St. Regis New York Hotel at Two E 55th Street, New York on Thursday, September 6th at 5:05 pm Eastern Time. An audio webcast of the presentation will be available on the Investor section of the STRATA website at www.strataskinsciences.com.
- Thomson Reuters StreetEvents•2 months ago
Edited Transcript of SSKN earnings conference call or presentation 13-Aug-18 8:30pm GMT
Q2 2018 STRATA Skin Sciences Inc Earnings Call
- GlobeNewswire•2 months ago
STRATA Skin Sciences Announces Strategic Agreement with a Large Private Equity Backed Group of Dermatology Clinics
STRATA Skin Sciences, Inc. (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, today announced the signing of a strategic marketing agreement with one of the nations’ largest private equity backed dermatology groups. The agreement allows for deployment across the group’s network of dozens of clinics to place the XTRAC® excimer laser and to utilize STRATA’s unique XTRAC value-add business model.
- GlobeNewswire•2 months ago
STRATA Skin Sciences Reports Second Quarter 2018 Financial Results
Conference call and webcast, today at 4:30 pm Eastern Time. HORSHAM, Pa., Aug. 13, 2018-- STRATA Skin Sciences, Inc. a medical technology company in Dermatology and Plastic Surgery dedicated to developing, ...
- ACCESSWIRE•2 months ago
STRATA Skin Sciences, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / August 13, 2018 / STRATA Skin Sciences, Inc. (NASDAQ: SSKN ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 13, 2018 at 4:30 PM Eastern ...
- GlobeNewswire•2 months ago
STRATA Skin Sciences Announces FDA Granted 510(k) Clearance for the Multi Micro Dose™ Tip for its XTRAC® 308nm Excimer Laser
STRATA Skin Sciences (SSKN) (“STRATA”), a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced that the U.S. Food and Drug Administration (“FDA”) has granted a 510(k) clearance to the Company for its Multi-Micro Dose™ (“MMD”) tip accessory for its proprietary XTRAC® 308nm excimer laser. The Multi-Micro Dose Tip accessory is indicated for use in conjunction with the XTRAC laser system to filter the Narrow Band -UVB (“NB-UVB”) light at delivery in order to calculate and individualize the maximum non-blistering dose for a particular patient. The patent-pending MMD Tip simultaneously applies multiple level doses of energy to a specific area of the patient’s psoriatic plaque, thereby identifying the maximum sub-blistering energy dose for a particular treatment zone. Utilizing the results from these test patches, the physician can design the optimal therapeutic dose treatment for each patient. The optimization of the dose levels should result in a shorter treatment regimen to achieve clearance.
- GlobeNewswire•2 months ago
STRATA Skin Sciences to Host 2nd Quarter 2018 Financial Results and Business Update Conference call on Monday, August 13, 2018
HORSHAM, Pa., Aug. 02, 2018-- STRATA Skin Sciences, Inc., a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing and marketing innovative products for ...
- Zacks•3 months ago
Top 10 Stocks Under $20
Today we've highlighted ten stocks that are currently trading for under $20 per share. All of these stocks currently have at least a Zacks Rank #2 (Buy), and a variety of other factors make these companies stand out as having strong upside potential.
- GlobeNewswire•3 months ago
STRATA Skin Sciences Announces Licensing Agreement for Certain MelaFind Assets
STRATA Skin Sciences (SSKN) (“STRATA”) a medical technology company in Dermatology and Plastic Surgery dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, today announced a fully paid exclusive and perpetual license agreement with a strategic entity for a de-identified digital image library of pigmented lesions and their related documentary information, related to STRATA’s discontinued MelaFind device. STRATA retains all intellectual property rights related to the MelaFind device and product line, including patents, design files and PMA approval to market. The strategic entity will be allowed exclusive rights to the de-identified digital images. “We are pleased to come to agreement with this licensing partner for the de-identified images related to the MelaFind device. Rationalizing the MelaFind assets is one step in our ongoing strategic turn-around efforts following our recent financing,” said Dr. Dolev Rafaeli, chief executive officer of STRATA.
- Zacks•3 months ago
Has Strata Skin Sciences (SSKN) Outpaced Other Medical Stocks This Year?
Is (SSKN) Outperforming Other Medical Stocks This Year?
- Simply Wall St.•4 months ago
When Will STRATA Skin Sciences Inc (NASDAQ:SSKN) Breakeven?
STRATA Skin Sciences Inc’s (NASDAQ:SSKN): STRATA Skin Sciences, Inc., a medical technology company, focuses on the therapeutic and aesthetic dermatology market. The US$60.50m market-cap posted a loss in its mostRead More...
- Simply Wall St.•4 months ago
Who Are The Largest Shareholders In STRATA Skin Sciences Inc (NASDAQ:SSKN)?
In this article, I’m going to take a look at STRATA Skin Sciences Inc’s (NASDAQ:SSKN) latest ownership structure, a non-fundamental factor which is important, but remains a less discussed subjectRead More...
- Simply Wall St.•5 months ago
Is STRATA Skin Sciences Inc’s (NASDAQ:SSKN) Balance Sheet A Threat To Its Future?
While small-cap stocks, such as STRATA Skin Sciences Inc (NASDAQ:SSKN) with its market cap of US$7.92M, are popular for their explosive growth, investors should also be aware of their balanceRead More...
